Involvement of liver kinase B1 in the ameliorative action of epigallocatechin-3-gallate against MAFLD progression in mice
Metabolic dysfunction-associated fatty liver disease (MAFLD) is characterized by intrahepatic fat accumulation in individuals without a history of excessive alcohol consumption. This study investigated the effects of epigallocatechin-3-gallate (EGCG) on reducing MAFLD severity. Twenty-four ddY mice...
Saved in:
| Main Authors: | Mahardian Rahmadi, Chia-Wei Phan, Santhra Segaran Balan, Athallah Syauqi Zumarthana, Ellyna Majesty Ayundari, Ismailia Wienda Yasmin Pratama Putri, Salsabila, Ahmad Dzulfikri Nurhan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2025-08-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/159024/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigallocatechin Gallate Ameliorates Nicotine Withdrawal Conditions-Induced Somatic and Affective Behavior Changes in Mice and Its Molecular Mechanism
by: Mahardian Rahmadi, et al.
Published: (2023-01-01) -
Comparative study of anti-inflammatory, antioxidant and antibacterial activities of epigallocatechin gallate, epigallocatechin, epicatechin gallate and epicatechin in vitro
by: Shuqi Wang, et al.
Published: (2025-06-01) -
Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
by: Kyoung-jin Min, et al.
Published: (2014-03-01) -
Therapeutic effects of epigallocatechin and epigallocatechin gallate on the allergic reaction of αs1-casein sensitized mice
by: Qianqian Zhang, et al.
Published: (2023-05-01) -
Effects of Epigallocatechin-3-<i>O</i>-Gallate on Bone Health
by: Patrycja Wróbel, et al.
Published: (2025-07-01)